Chapter/Section Purchase

1 Study Coverage
1.1 Antihypertensive Product Introduction
1.2 Market by Type
1.2.1 Global Antihypertensive Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Diuretics
1.2.3 Angiotensin Converting Enzyme (ACE) Inhibitors
1.2.4 Angiotensin Receptor Blockers (ARBs)
1.2.5 Calcium Channel Blockers
1.2.6 Beta Blockers
1.2.7 Alpha Blockers
1.2.8 Vasodilators & Renin Inhibitors
1.3 Market by Application
1.3.1 Global Antihypertensive Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antihypertensive Sales Estimates and Forecasts 2017-2028
2.2 Global Antihypertensive Revenue Estimates and Forecasts 2017-2028
2.3 Global Antihypertensive Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Antihypertensive Sales by Region
2.4.1 Global Antihypertensive Sales by Region (2017-2022)
2.4.2 Global Sales Antihypertensive by Region (2023-2028)
2.5 Global Antihypertensive Revenue by Region
2.5.1 Global Antihypertensive Revenue by Region (2017-2022)
2.5.2 Global Antihypertensive Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Antihypertensive Sales by Manufacturers
3.1.1 Global Top Antihypertensive Manufacturers by Sales (2017-2022)
3.1.2 Global Antihypertensive Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antihypertensive in 2021
3.2 Global Antihypertensive Revenue by Manufacturers
3.2.1 Global Antihypertensive Revenue by Manufacturers (2017-2022)
3.2.2 Global Antihypertensive Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Antihypertensive Revenue in 2021
3.3 Global Antihypertensive Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Antihypertensive Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Antihypertensive Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antihypertensive Sales by Type
4.1.1 Global Antihypertensive Historical Sales by Type (2017-2022)
4.1.2 Global Antihypertensive Forecasted Sales by Type (2023-2028)
4.1.3 Global Antihypertensive Sales Market Share by Type (2017-2028)
4.2 Global Antihypertensive Revenue by Type
4.2.1 Global Antihypertensive Historical Revenue by Type (2017-2022)
4.2.2 Global Antihypertensive Forecasted Revenue by Type (2023-2028)
4.2.3 Global Antihypertensive Revenue Market Share by Type (2017-2028)
4.3 Global Antihypertensive Price by Type
4.3.1 Global Antihypertensive Price by Type (2017-2022)
4.3.2 Global Antihypertensive Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Antihypertensive Sales by Application
5.1.1 Global Antihypertensive Historical Sales by Application (2017-2022)
5.1.2 Global Antihypertensive Forecasted Sales by Application (2023-2028)
5.1.3 Global Antihypertensive Sales Market Share by Application (2017-2028)
5.2 Global Antihypertensive Revenue by Application
5.2.1 Global Antihypertensive Historical Revenue by Application (2017-2022)
5.2.2 Global Antihypertensive Forecasted Revenue by Application (2023-2028)
5.2.3 Global Antihypertensive Revenue Market Share by Application (2017-2028)
5.3 Global Antihypertensive Price by Application
5.3.1 Global Antihypertensive Price by Application (2017-2022)
5.3.2 Global Antihypertensive Price Forecast by Application (2023-2028)
6 North America
6.1 North America Antihypertensive Market Size by Type
6.1.1 North America Antihypertensive Sales by Type (2017-2028)
6.1.2 North America Antihypertensive Revenue by Type (2017-2028)
6.2 North America Antihypertensive Market Size by Application
6.2.1 North America Antihypertensive Sales by Application (2017-2028)
6.2.2 North America Antihypertensive Revenue by Application (2017-2028)
6.3 North America Antihypertensive Market Size by Country
6.3.1 North America Antihypertensive Sales by Country (2017-2028)
6.3.2 North America Antihypertensive Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Antihypertensive Market Size by Type
7.1.1 Europe Antihypertensive Sales by Type (2017-2028)
7.1.2 Europe Antihypertensive Revenue by Type (2017-2028)
7.2 Europe Antihypertensive Market Size by Application
7.2.1 Europe Antihypertensive Sales by Application (2017-2028)
7.2.2 Europe Antihypertensive Revenue by Application (2017-2028)
7.3 Europe Antihypertensive Market Size by Country
7.3.1 Europe Antihypertensive Sales by Country (2017-2028)
7.3.2 Europe Antihypertensive Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antihypertensive Market Size by Type
8.1.1 Asia Pacific Antihypertensive Sales by Type (2017-2028)
8.1.2 Asia Pacific Antihypertensive Revenue by Type (2017-2028)
8.2 Asia Pacific Antihypertensive Market Size by Application
8.2.1 Asia Pacific Antihypertensive Sales by Application (2017-2028)
8.2.2 Asia Pacific Antihypertensive Revenue by Application (2017-2028)
8.3 Asia Pacific Antihypertensive Market Size by Region
8.3.1 Asia Pacific Antihypertensive Sales by Region (2017-2028)
8.3.2 Asia Pacific Antihypertensive Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Antihypertensive Market Size by Type
9.1.1 Latin America Antihypertensive Sales by Type (2017-2028)
9.1.2 Latin America Antihypertensive Revenue by Type (2017-2028)
9.2 Latin America Antihypertensive Market Size by Application
9.2.1 Latin America Antihypertensive Sales by Application (2017-2028)
9.2.2 Latin America Antihypertensive Revenue by Application (2017-2028)
9.3 Latin America Antihypertensive Market Size by Country
9.3.1 Latin America Antihypertensive Sales by Country (2017-2028)
9.3.2 Latin America Antihypertensive Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Antihypertensive Market Size by Type
10.1.1 Middle East and Africa Antihypertensive Sales by Type (2017-2028)
10.1.2 Middle East and Africa Antihypertensive Revenue by Type (2017-2028)
10.2 Middle East and Africa Antihypertensive Market Size by Application
10.2.1 Middle East and Africa Antihypertensive Sales by Application (2017-2028)
10.2.2 Middle East and Africa Antihypertensive Revenue by Application (2017-2028)
10.3 Middle East and Africa Antihypertensive Market Size by Country
10.3.1 Middle East and Africa Antihypertensive Sales by Country (2017-2028)
10.3.2 Middle East and Africa Antihypertensive Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Antihypertensive Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Antihypertensive Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Norvatis
11.2.1 Norvatis Corporation Information
11.2.2 Norvatis Overview
11.2.3 Norvatis Antihypertensive Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Norvatis Antihypertensive Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Norvatis Recent Developments
11.3 Merck & Co.
11.3.1 Merck & Co. Corporation Information
11.3.2 Merck & Co. Overview
11.3.3 Merck & Co. Antihypertensive Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck & Co. Antihypertensive Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck & Co. Recent Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Overview
11.4.3 Sanofi Antihypertensive Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sanofi Antihypertensive Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Overview
11.5.3 AstraZeneca Antihypertensive Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 AstraZeneca Antihypertensive Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AstraZeneca Recent Developments
11.6 GSK
11.6.1 GSK Corporation Information
11.6.2 GSK Overview
11.6.3 GSK Antihypertensive Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 GSK Antihypertensive Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GSK Recent Developments
11.7 Daiichi-Sankyo
11.7.1 Daiichi-Sankyo Corporation Information
11.7.2 Daiichi-Sankyo Overview
11.7.3 Daiichi-Sankyo Antihypertensive Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Daiichi-Sankyo Antihypertensive Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Daiichi-Sankyo Recent Developments
11.8 Boehringer-Ingelheim
11.8.1 Boehringer-Ingelheim Corporation Information
11.8.2 Boehringer-Ingelheim Overview
11.8.3 Boehringer-Ingelheim Antihypertensive Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Boehringer-Ingelheim Antihypertensive Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Boehringer-Ingelheim Recent Developments
11.9 Bayer
11.9.1 Bayer Corporation Information
11.9.2 Bayer Overview
11.9.3 Bayer Antihypertensive Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Bayer Antihypertensive Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Bayer Recent Developments
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Corporation Information
11.10.2 Johnson & Johnson Overview
11.10.3 Johnson & Johnson Antihypertensive Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Johnson & Johnson Antihypertensive Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Johnson & Johnson Recent Developments
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Corporation Information
11.11.2 Bristol-Myers Squibb Overview
11.11.3 Bristol-Myers Squibb Antihypertensive Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Bristol-Myers Squibb Antihypertensive Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Bristol-Myers Squibb Recent Developments
11.12 Tekeda
11.12.1 Tekeda Corporation Information
11.12.2 Tekeda Overview
11.12.3 Tekeda Antihypertensive Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Tekeda Antihypertensive Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Tekeda Recent Developments
11.13 Ranbaxy Laboratories
11.13.1 Ranbaxy Laboratories Corporation Information
11.13.2 Ranbaxy Laboratories Overview
11.13.3 Ranbaxy Laboratories Antihypertensive Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Ranbaxy Laboratories Antihypertensive Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Ranbaxy Laboratories Recent Developments
11.14 Shihuida Pharm
11.14.1 Shihuida Pharm Corporation Information
11.14.2 Shihuida Pharm Overview
11.14.3 Shihuida Pharm Antihypertensive Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Shihuida Pharm Antihypertensive Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Shihuida Pharm Recent Developments
11.15 Second Pharmaceutical
11.15.1 Second Pharmaceutical Corporation Information
11.15.2 Second Pharmaceutical Overview
11.15.3 Second Pharmaceutical Antihypertensive Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Second Pharmaceutical Antihypertensive Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Second Pharmaceutical Recent Developments
11.16 Lupin Limited.
11.16.1 Lupin Limited. Corporation Information
11.16.2 Lupin Limited. Overview
11.16.3 Lupin Limited. Antihypertensive Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Lupin Limited. Antihypertensive Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Lupin Limited. Recent Developments
11.17 Yangtze River Pharmaceutical
11.17.1 Yangtze River Pharmaceutical Corporation Information
11.17.2 Yangtze River Pharmaceutical Overview
11.17.3 Yangtze River Pharmaceutical Antihypertensive Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Yangtze River Pharmaceutical Antihypertensive Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Yangtze River Pharmaceutical Recent Developments
11.18 Hengrui Medicine
11.18.1 Hengrui Medicine Corporation Information
11.18.2 Hengrui Medicine Overview
11.18.3 Hengrui Medicine Antihypertensive Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Hengrui Medicine Antihypertensive Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Hengrui Medicine Recent Developments
11.19 Qilu Pharmaceutical
11.19.1 Qilu Pharmaceutical Corporation Information
11.19.2 Qilu Pharmaceutical Overview
11.19.3 Qilu Pharmaceutical Antihypertensive Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Qilu Pharmaceutical Antihypertensive Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Qilu Pharmaceutical Recent Developments
11.20 HUALON
11.20.1 HUALON Corporation Information
11.20.2 HUALON Overview
11.20.3 HUALON Antihypertensive Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 HUALON Antihypertensive Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 HUALON Recent Developments
11.21 Dawnrays
11.21.1 Dawnrays Corporation Information
11.21.2 Dawnrays Overview
11.21.3 Dawnrays Antihypertensive Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Dawnrays Antihypertensive Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Dawnrays Recent Developments
11.22 HISUN Pharmceutical
11.22.1 HISUN Pharmceutical Corporation Information
11.22.2 HISUN Pharmceutical Overview
11.22.3 HISUN Pharmceutical Antihypertensive Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 HISUN Pharmceutical Antihypertensive Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 HISUN Pharmceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Antihypertensive Industry Chain Analysis
12.2 Antihypertensive Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antihypertensive Production Mode & Process
12.4 Antihypertensive Sales and Marketing
12.4.1 Antihypertensive Sales Channels
12.4.2 Antihypertensive Distributors
12.5 Antihypertensive Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Antihypertensive Industry Trends
13.2 Antihypertensive Market Drivers
13.3 Antihypertensive Market Challenges
13.4 Antihypertensive Market Restraints
14 Key Findings in The Global Antihypertensive Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer